Continuity of essential health services in Kenya, Malawi and Mozambique

/in , , , , , , /by

This series of cross-sectional studies explores the effect of the COVID-19 pandemic on demand- and supply-side factors affecting maternal, newborn, and child health (MNCH) service utilization in Kenya, Malawi and Mozambique. The studies reveal the extent to which the COVID-19 pandemic impacted people’s willingness and ability to access essential MNCH services, their experiences of care, and the health system’s readiness to continue to provide essential care during the pandemic.

Source: Continuity of essential health services in Kenya, Malawi and Mozambique

    Views 409

    Public Service Announcement on Child Vaccination in Bangladesh

    /in , , , , , , , , , , /by

    This public service announcement raises awareness about the ongoing vaccination campaign for 5-11 years old children in Bangladesh.

    Source: Public Service Announcement on Child Vaccination in Bangladesh

    Views 113

    Considerations for Integrating COVID-19 Vaccination into Immunization Programmes and Primary Health Care for 2022 and beyond

    /in , , , , , /by

    This document lays out key programmatic considerations essential for moving from mass campaigns for COVID-19 vaccination to integrating COVID-19 vaccination into immunization programmes, PHC and other relevant health services for 2022 and beyond.

    The ultimate aim is to fully explore potential areas for integrating different components of immunization programmes, PHC and health systems. Given the evolving epidemiological nature of the COVID-19 pandemic, this is a living document and will be updated to reflect the changing context, including as policies for COVID-19 vaccinations over the longer term are formulated. Finally, the document is not intended to outline a prescriptive approach but rather to present considerations and options for countries to consider and apply based on their needs and the country context.

    Source: Considerations for Integrating COVID-19 Vaccination into Immunization Programmes and Primary Health Care for 2022 and beyond

      Views 371

      Testimonials from community leaders on the awareness activities against COVID-19 carried out by Breakthrough ACTION Mali

      /in , , , , , , , , , /by

      Under funding from USAID Mali, Breakthrough ACTION Mali conducted advocacy and mobilization, awareness-raising and community engagement activities for several months in the capital of Bamako but also in the regions. These activities have been proven by the various testimonies of government, community and religious leaders.

      Source: Testimonials from community leaders on the awareness activities against COVID-19 carried out by Breakthrough ACTION Mali

      Views 165

      Mental Health GAP Intervention Guide

      /in , /by

      The ‘mhGAP Intervention Guide (mhGAP-IG) for mental, neurological and substance use (MNS) disorders in non-specialist health settings’ is for use by doctors, nurses, other health workers as well as health planners and managers. The Intervention Guide presents the integrated management of priority MNS conditions using algorithms for clinical decision making. Additionally, it comprises a streamlined and simplified clinical assessment that includes an algorithm for follow-up; modules on Essential Care and Practice, Psychoses, Child and Adolescent Mental and Behavioural Disorders and Disorders due to Substance Use.

      Source: Mental Health GAP Intervention Guide

      Views 74

      How Theory Based Programming can drive COVID-19 Vaccine Uptake: A Program Brief from Nigeria

      /in , , , , , , /by

      This Program Brief describes how Breakthrough ACTION Nigeria used theory-based programming to drive vaccine uptake through social and behavior change programming.

      Source: How Theory Based Programming can drive COVID-19 Vaccine Uptake: A Program Brief from Nigeria

      Views 326

      Lessons from research on perceptions of COVID-19 vaccination for pregnant women in Côte d’Ivoire – January 2023

      /in , , , , /by

      Although the population of Côte d’Ivoire has reached 58% of the vaccination target, there is still work to be done to encourage people with doubts to get vaccinated. The government of Côte d’Ivoire has authorized the Pfizer vaccine for pregnant women since January 2023 (Circular 00103/2023). Breakthrough ACTION supports the government of Côte d’Ivoire through social and behavior change (SBC) interventions, including research and monitoring to inform COVID-19 vaccination activities. The Breakthrough ACTION team, in partnership with the Department of Health and USAID, collected qualitative data from three sites to assess concern about COVID-19, perceptions of the current vaccine rollout, standards perceptions around vaccination, how misinformation and other factors influence vaccine uptake. This analysis focuses on a subset of data relating to perceptions of COVID-19 among pregnant women.

      Source: Lessons from research on perceptions of COVID-19 vaccination for pregnant women in Côte d’Ivoire – January 2023

      Views 106

      Lessons from the research on perceptions of COVID-19 vaccination for people living with comorbidities in Côte d’Ivoire – January 2023

      /in , , , , , , /by

      Côte d’Ivoire has recorded 87,966 confirmed COVID-19 cases, 87,129 recovered and 833 deaths and 25,263,932 doses administered, and 59% vaccination target coverage (as of 02/09/23, MSHPCMU). Eligible for the vaccine since the start of vaccination in Côte d’Ivoire, 9% of carriers of chronic pathologies have received at least one dose and 5% have been completely vaccinated (Point of 09/02/23, MSHPCMU). The Breakthrough ACTION project through USAID funding, supports the government of Côte d’Ivoire through social and behavior change (SBC) interventions, including research and monitoring to inform COVID-19 vaccination activities. Breakthrough ACTION collected qualitative data across three sites (Abidjan – Bouaké – San Pedro) to assess perceptions of the COVID-19 vaccine. This analysis focuses on the perceptions of COVID-19 among people living with a comorbidity (diabetes, hypertension, obesity, HIV, etc.).

      Source: Lessons from the research on perceptions of COVID-19 vaccination for people living with comorbidities in Côte d’Ivoire – January 2023

      Views 86

      Survey on Knowledge, Attitudes and Practices (KAP) in the context of prevention against COVID-19 Côte d’Ivoire, Phase 3

      /in , , , , /by

      Since the emergence of the SARS-CoV2 virus and its first detection in Côte d’Ivoire in March 2020, the country has recorded 87,891 cases and 830 deaths (November 2022). The Ministry of Health has taken various measures to reduce the spread and impact of COVID-19, including the authorization of COVID-19 vaccines AstraZeneca, Pfizer, Sinopharm and Johnson & Johnson (J&J). With some ambitious goals to vaccinate 70% of the Ivorian population, understanding the drivers of confidence and uptake of vaccines is essential for the response to COVID-19 and achieving this goal.

      Breakthrough ACTION Côte d’Ivoire conducted a three-phase household survey of knowledge, attitudes and practices to inform risk communication and community engagement.

      • All 3 phases carried out in Abidjan
      • Phase 3, conducted in Abidjan and three inland sites
      • Random sampling in clusters
      • Data collected on tablets and
      • extracted daily to be cleaned and analyzed

      Source: Survey on Knowledge, Attitudes and Practices (KAP) in the context of prevention against COVID-19 Côte d’Ivoire, Phase 3

      Views 75